オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - olmesartan medoxomil, quantity: 10 mg - tablet, film coated - excipient ingredients: hyprolose; hypromellose; purified talc; lactose monohydrate; magnesium stearate; microcrystalline cellulose; titanium dioxide - olmesartan astron is indicated for the treatment of hypertension.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; lactose monohydrate; purified talc; titanium dioxide; hypromellose; hyprolose - olmesartan astron is indicated for the treatment of hypertension.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: magnesium stearate; purified talc; hypromellose; lactose monohydrate; titanium dioxide; microcrystalline cellulose; hyprolose - olmesartan astron is indicated for the treatment of hypertension.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 100 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium stearylfumarate; sodium starch glycollate; microcrystalline cellulose; sunset yellow fcf aluminium lake; tartrazine aluminium lake - levothyroxine astron is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine astron is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 137 microgram - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; light magnesium oxide; sodium stearylfumarate; brilliant blue fcf aluminium lake - levothyroxine astron is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine astron is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 25 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; microcrystalline cellulose; sodium stearylfumarate; sodium starch glycollate; sunset yellow fcf aluminium lake - levothyroxine astron is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine astron is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 175 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium starch glycollate; microcrystalline cellulose; sodium stearylfumarate; brilliant blue fcf aluminium lake; carmine - levothyroxine astron is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine astron is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 50 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; microcrystalline cellulose; sodium stearylfumarate; sodium starch glycollate - levothyroxine astron is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine astron is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 200 microgram - tablet, uncoated - excipient ingredients: sodium starch glycollate; sodium stearylfumarate; light magnesium oxide; microcrystalline cellulose; allura red ac aluminium lake - levothyroxine astron is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine astron is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 125 microgram - tablet, uncoated - excipient ingredients: sodium starch glycollate; microcrystalline cellulose; light magnesium oxide; sodium stearylfumarate; sunset yellow fcf aluminium lake; brilliant blue fcf aluminium lake; allura red ac aluminium lake - levothyroxine astron is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine astron is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.